Literature DB >> 8947599

Hierarchic T-cell help to non-linked B-cell epitopes.

N H Brons1, A Blaich, K H Wiesmüller, F Schneider, G Jung, C P Muller.   

Abstract

The induction of antibodies against peptides requires the presence of a T helper cell epitope. In the absence of an added T-cell epitope only 10% of the mice, or less depending on the strain, gave an antibody response to a series of peptides of the measles virus (MV) fusion (F) protein. After coimmunization with a non-covalently coupled T-cell epitope more than 60% of the peptides became immunogenic. Considerable differences became apparent when BALB/c mice were immunized with peptides in the presence of different T-cell epitopes. An immunodominant T-cell epitope of the MV-F protein was more efficient than a subdominant or a cryptic T-cell epitope in providing help to a non-linked B-cell epitope. There is both a ranking order of the amount of help which B-cell epitopes require and a ranking order for the help T-cell epitopes are able to provide. The capability of a T-cell epitope to provide help to a B-cell epitope correlated with its own immunogenicity, i.e. the intensity of the antibody response to the peptide representing the T-cell epitope. The data suggest that for each MHC class II allele there is an optimal T-cell epitope which can provide help to a maximal number of B-cell epitopes and that such a peptide can be identified by its ability to induce antibodies against itself. By using this strategy, the authors were able to induce antibodies which cross-reacted with the MV.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8947599     DOI: 10.1046/j.1365-3083.1996.d01-336.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  4 in total

1.  Identification of canine helper T-cell epitopes from the fusion protein of canine distemper virus.

Authors:  S Ghosh; J Walker; D C Jackson
Journal:  Immunology       Date:  2001-09       Impact factor: 7.397

Review 2.  Removal of B cell epitopes as a practical approach for reducing the immunogenicity of foreign protein-based therapeutics.

Authors:  Satoshi Nagata; Ira Pastan
Journal:  Adv Drug Deliv Rev       Date:  2009-08-11       Impact factor: 15.470

3.  Mutagenic Deimmunization of Diphtheria Toxin for Use in Biologic Drug Development.

Authors:  Joerg U Schmohl; Deborah Todhunter; Seung Oh; Daniel A Vallera
Journal:  Toxins (Basel)       Date:  2015-10-10       Impact factor: 4.546

Review 4.  Addressing the Immunogenicity of the Cargo and of the Targeting Antibodies with a Focus on Demmunized Bacterial Toxins and on Antibody-Targeted Human Effector Proteins.

Authors:  Yehudit Grinberg; Itai Benhar
Journal:  Biomedicines       Date:  2017-06-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.